Log in to search using one of your social media accounts:

 

AlloSource touts completion of bioengineered blood vessels for Humacyte trial
Tissue-provider AlloSource said this week it completed production of investigational bioengineered blood vessels designed for Humacyte‘s Phase III clinical trial exploring the use of the vessels to improve vascular access for hemodialysis patients with end-stage renal failure. The trail aims to compare the efficacy of the bioengineered human-tissue vessels to current synthetic vessels made from expanded polytetrafluoroethylene, Centennial, Colo.-based Allosource said. “AlloSource’s partnership with Humacyte supports our focus on regenerative medicine. Our organizations share a deep commitment to developin...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Research & Development Vascular allosource Humacyte Source Type: news

Medtronic readies pivotal trial in renal denervation
Medtronic (NYSE:MDT) said today that it’s ready for a run at FDA approval for renal denervation in treating high blood pressure, more than three years after the failure of a high-profile clinical trial. Back in January 2014, Fridley, Minn.-based Medtronic shocked medtech when it announced that the highly anticipated Symplicity HTN-3 trial, examining ablation of the around the renal arteries in treating hypertension, failed to meet its efficacy endpoint. The company suspended enrollment in its other Symplicity trials around the world and later took a $200 million write-down on its renal denervation assets. News o...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Wall Street Beat Medtronic Renal Source Type: news

HKBU clinical observation finds efficacy rate of over 70 percent in Chinese medicine treatment of chronic renal failure
(Hong Kong Baptist University) The School of Chinese Medicine of Hong Kong Baptist University recently conducted a clinical observation on Chinese medicine treatment of chronic renal failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

Cardiac ICU patient composition is changing over time
(Michigan Medicine - University of Michigan) A new University of Michigan study finds slightly more than half of heart patients are admitted to the CICU for noncardiac conditions, such as sepsis or renal failure, rather than for a heart condition. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 16, 2017 Category: Infectious Diseases Source Type: news

To Empower Women Is to Empower Nations: Stories from Iraq and Afghanistan
August 01, 2017As a health worker in a conflict zone, I  learned what it means to be in the right place at the right time.Being in the right place at the right time —I never had a full understanding of that concept until I started my medical career.Before coming to the United States to get a master ’s degree in public health at the University of North Carolina at Chapel Hill, I was a physician at Al-Zahrawi Surgical Hospital in the south of Iraq, one of only two main hospitals in the city of Amarah, inhabited by aboutone million people.Such conditions make complications more frequent.We were 20 new doctors...
Source: IntraHealth International - August 1, 2017 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Older mothers have higher rates of severe complications in childbirth
(PLOS) The risk of potentially life-threatening morbidity around childbirth, such as renal failure, obstetric shock, and amniotic fluid embolism, increases in older mothers, according to a study published by Sarka Lisonkova from the University of British Columbia, Canada and colleagues in PLOS Medicine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 30, 2017 Category: International Medicine & Public Health Source Type: news

No-touch ’ heart bypass surgery reduces strokes
Four surgical methods of coronary artery bypass grafting with increasing degrees of aortic manipulation. Percentages pictured represent the relative decrease in risk of perioperative stroke using anOPCABG compared to the other techniques. [Image from the researchers]]A recent study from the University of Sydney and Sydney Heart and Lung Surgeons has shown that a new “no-touch” beating heart bypass surgery technique has reduced post-operative stroke by 78%. The procedure, known as an OPCABG, also reduced post-operative mortality by 50% compared to traditional coronary artery bypass grafting. It reduced renal fai...
Source: Mass Device - May 17, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular CABG MedTech Sydney Heart and Lung Surgeons University of Sydney Source Type: news

HRS 2017: Two-year registry data on Boston Scientific ’ s S-ICD
Data from a long-term post-approval registry study of the S-ICD subcutaneous pacemaker made by Boston Scientific (NYSE:BSX) showed high successful implantation rates and “acceptable” short-term complication rates, researchers said today at the annual Heart Rhythm Society conference in Chicago. The study looked at data from 1,637 S-ICD patients who met the criteria for implantable cardioverter defibrillator implantation, passed at least 1 electrocardiogram screening vector and had a life expectancy of more than 1 year. The mean follow-up time was 2 years and the study plans to follow patients out ...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Boston Scientific Cardiac Rhythm Management hrs2017 Source Type: news

Acute renal failure caused by Amanita oberwinklerana poisoning - Fu X, Fu B, He Z, Gong M, Li Z, Chen Z.
Mushrooms of the sections Lepidella and Amidella in the genus Amanita can cause acute renal injury. The paper reports the first two known cases of acute renal failure after ingestion of A. oberwinklerana in China. The cases' clinical symptoms were characte... (Source: SafetyLit)
Source: SafetyLit - May 4, 2017 Category: Global & Universal Tags: Poisoning Source Type: news

Gender Differences ID'd for Complications After Joint Replacement
(MedPage Today) -- Among them: renal failure for men, UTIs for women (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 17, 2017 Category: Psychiatry Source Type: news

Elucidated connection between renal failure and'bad' mitochondria described
Scientists describe an elucidated connection between renal failure and'bad'mitochondria in a new report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 15, 2017 Category: Science Source Type: news

Elucidated connection between renal failure and 'bad' mitochondria described
(Lomonosov Moscow State University) Biologists from the A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University suggested the approach to prevent kidney injury after ischemia. Moreover, the scientists explained why these mechanisms become non-protective in kidney of an old organism. The results of the study are published in the Scientific Reports journal. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 15, 2017 Category: Biology Source Type: news

Despite stock backlash, reverse split moves Sunshine Heart back into NASDAQ ’ s good graces
Sunshine Heart (NSDQ:SSH) said today that NASDAQ gave official word that the company was complying with its $1 minimum bid price requirement. The news comes after the Eden Prairie, Minn.-based company pulled the trigger on a 1-for-30 reverse stock split last month, a move that sent shares tumbling. Shares dropped approximately 38% since the split went into effect on Jan. 13. In trading today, shares have seen an over 2% drop, at $5.44 as of 4:00 p.m. EST. The company said it remains “subject to an extension through March 20, 2017 to evidence compliance with Nasdaq’s $2.5 million stockholders’ equity ...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Sunshine Heart Inc. Source Type: news

Washington Supreme Court deals a blow to Intuitive Surgical
Intuitive Surgical (NSDQ:ISRG) must face another trial over whether it gave adequate warnings about using its da Vinci robot-assisted surgery platform in prostatectomies after a botched surgery in which a doctor failed to heed its warnings, the Washington Supreme Court ruled yesterday. Plaintiff Fred Taylor went in for a prostatectomy in September 2008. During the procedure, Dr. Scott Bildsten noticed that Taylor’s rectal wall was lacerated and converted from robot-assisted to open surgery, according to court documents. “Taylor’s quality of life was poor after the surgery. He suffered respirator...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Product Liability Robot-Assisted Surgery Intuitive Surgical Source Type: news

Efforts To Prolong My Husband's Life Cost Him An Easy Death
For the past seven months, I’ve carried around my husband’s advance medical directive in my purse. During this time, I’ve shown this lawyer-prepared and notarized document to dozens of doctors, nurses, ambulance crews, surgeons, dialysis center teams, hospital emergency room workers and administrators, intake staff, nurse practitioners, nursing home staff, medical transportation drivers, and others. I’m an expert in summarizing its contents, and my 11-second elevator pitch goes like this: Do not resuscitate. No heroic measures. A gentle and peaceful death, pain-free and with dignity. Please. Af...
Source: Healthy Living - The Huffington Post - January 26, 2017 Category: Consumer Health News Source Type: news

Sunshine Heart tumbles on 1-30 reverse split
Shares in Sunshine Heart (NSDQ:SSH) fell slightly today after it announced a 1-for-30 reverse split of its common stock. The company’s common stock will continue to trade under the same symbol on the NASDAQ market. SSH shares were trading at $8.40 apiece in afternoon activity, down -5%. At the company’s stockholders meeting on January 9, the board of directors approved the company’s decision to effect a reverse stock split somewhere between 1-for-20 and 1-for-60. In September last year, Sunshine Heart realigned its strategy to focus on its recently acquired Aquadex FlexFlow system, designed to f...
Source: Mass Device - January 13, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiac Assist Devices Cardiovascular Wall Street Beat Sunshine Heart Inc. Source Type: news

PCI Without Contrast in Advanced Renal Failure PCI Without Contrast in Advanced Renal Failure
The authors report on a novel strategy for safely performing PCI without the use of contrast in patients with advanced chronic kidney disease.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Fetal and Neonatal Renal Failure and Renal Transplant
Major advances have been made over the past few decades in caring for neonates with chronic renal disease. Although dialysis registries report infants as a high-risk population for poor outcomes, these children can be effectively maintained on dialysis until they are ready for receiving a transplant. Early identification of the presence of chronic renal disease is helpful in preparing for postnatal complications and to counsel parents on potential outcomes of infants with chronic kidney disease. (Source: NeoReviews recent issues)
Source: NeoReviews recent issues - November 30, 2016 Category: Pediatrics Authors: Wong, C. J. Tags: Pediatric Drug Labeling Update Complex Fetal Care Source Type: news

The Fallacy of Guidelines
I hate it when someone tries to tell me how I should take care of my patients. However, we are now working with the politics of "evidence-based medicine". This era is characterized by groups of "experts" who get together and compile guidelines on how best to manage various medical conditions. The fact that our knowledge of patient management is constantly changing is of little concern to these "experts" nor are they of concern to third party payers who insist that the guidelines be followed or they will not pay for the care provided. Guidelines are generally based on a review of the literatu...
Source: Healthy Living - The Huffington Post - November 4, 2016 Category: Consumer Health News Source Type: news

Sunshine Heart raises $3.8m
Sunshine Heart (NSDQ:SSH) said today it raised $3.8 million in a new offering with a “healthcare dedicated institutional investor” to support its Aquadex product line. The Eden Prairie, Minn.-based company said it inked a definitive agreement looking to float 2,900 registered shares of Series C convertible preferred stock. The shares of Series C convertible preferred stock are convertible for a total of 17 million shares of common stock at a price of 17¢ per share. Sunshine Heart said that, concurrent with the private placement, it is issuing 900 unregistered Series D convertible preferred stock ...
Source: Mass Device - November 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular Sunshine Heart Inc. Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 30, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Sunshine Heart shifts focus to Aquadex FlexFlow system Sunshine Heart said today it will realign its strategy to focus on its recently acquired Aquadex FlexFlow system, designed to filter water and salt from patients with fluid...
Source: Mass Device - September 30, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Sunshine Heart shifts focus to Aquadex FlexFlow system
Sunshine Heart (NSDQ:SSH) said today it will realign its strategy to focus on its recently acquired Aquadex FlexFlow system, designed to filter water and salt from patients with fluid overload due to renal failure. The Eden Prairie, Minn.-based company acquired the system from Baxter for $5 million in August this year. It also said it will pause clinical evaluations of its neuromodulation tech and reduce cash burn to $80,000 per month in the 4th quarter of 2016. The company is targeting $5 million in annual revenue for the Aquadex business in the 4th quarter of 2016, and $10 million in  the 4th quarter ...
Source: Mass Device - September 29, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiac Assist Devices Cardiovascular Sunshine Heart Inc. Source Type: news

What Causes Hyperphosphatemia?
Discussion Constipation is a common problem in general pediatrics and its causes are numerous. It can cause acute and recurrent abdominal pain and is a cause of abdominal distention. Patients who are young, whose presentations are other than routine or who had complications should be invested for underlying causes of their constipation. This patient had undergone some evaluations in the past for constipation but because of the presentation of sepsis a more rigorous evaluation was undertaken. The differential diagnoses of the following can be found here: constipation, acute abdominal pain, recurrent abdominal pain, and abdo...
Source: PediatricEducation.org - September 12, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

3 Drugs with the Most Severe Side Effects
Image Source Drugs have been known to have some sort of side effects on patients. Most of them are not often discussed in the health tabloids. While other drugs have side effects that are very nominal when compared to the benefits the patient derives from their usage, others have side effects that can impact the lives of their users forever. The most common side effects people experience from drug usage are gastrointestinal related issues which include constipation, nausea, and vomiting. Some other drugs can leave you feeling tired and dizzy for a short period of time. Combining these drugs with simple aspirin will usuall...
Source: Healthy Living - The Huffington Post - August 19, 2016 Category: Consumer Health News Source Type: news

This Boy Is Dying Of An Illness Doctors Can Treat, But Syria's War Won't Let Them
Up until a few weeks ago, 11-year-old Yaman Ezzedine could sleep through the night. Today, he lies awake suffering from the pain of meningitis in the besieged town of Madaya, Syria, waiting for the treatment he needs.  His mother, Khawalah Jabir, is desperate for aid. “I’m begging you, anyone, help us,” Jabir said. “Help us. No one is helping us.” For weeks, Yaman’s family has been appealing to aid organizations and the Syrian government to evacuate him so he can receive life-saving treatment for his illness. That treatment may never come. Yaman is one of many children trapped...
Source: Healthy Living - The Huffington Post - August 18, 2016 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Alere ticks up after reporting delayed 2015 results Shares in Alere ticked up today after the diagnostics giant reported its long-delayed financial results ahead of its $6 billion union with Abbott. Alere, which last month cut ...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Sunshine Heart pays $5m for Baxter ’ s Aquadex
Sunshine Heart (NSDQ:SSH) said today that it agreed to pay about $5 million for the Aquadex fluid filtration device Baxter (NYSE:BAX) acquired when it bought Gambro in 2013. The Aquadex device is designed to filter salt and water in patients with renal failure experiencing fluid overload. The deal calls for Eden Prairie, Minn.-based Sunshine Heart to pay $4 million in cash and another 1 million in SSH shares, worth about $950,000 at their August 5 closing price of 95¢ apiece. Baxter paid $3.9 billion to acquire Swedish dialysis giant Gambro and the Aquadex device in September&nb...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Mergers & Acquisitions Wall Street Beat Baxter International Sunshine Heart Inc. Source Type: news

Africa: Chronic Diseases Need State Action
[Daily News] Medical practitioners and researchers in the country want the government to start thinking about providing free treatment for chronic diseases like renal failure, hypertension and diabetes for the benefit of people on antiretroviral drugs. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 4, 2016 Category: Infectious Diseases Source Type: news

Genetics Home Reference: action myoclonus-renal failure syndrome
https://ghr.nlm.nih.gov/condition/action-myoclonus-renal-failure-syndrome (Source: NLM General Announcements)
Source: NLM General Announcements - June 21, 2016 Category: Databases & Libraries Source Type: news

Gout Drug Fends Off Renal Failure (CME/CE)
(MedPage Today) -- Risks were lowest for dosages of 300 mg/day or higher (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 15, 2016 Category: Geriatrics Source Type: news

RAS Inhibitors and Kidney, CV Outcomes in Patients With CKDRAS Inhibitors and Kidney, CV Outcomes in Patients With CKD
How is the risk for renal failure and cardiovascular events impacted in patients with chronic kidney disease treated with RAS inhibitors? American Journal of Kidney Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2016 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Lupus patients 'at higher risk of developing other health conditions'
People with lupus are at a greater risk of developing other health conditions than members of the general population.This is according to a new study conducted by the University of Nottingham and the Arthritis Research UK Primary Care Centre at Keele University, which examined the frequency of comorbidities associated with systemic lupus erythematosus in the UK between 1999 and 2012.A broad UK study Published in the medical journal Arthritis Care & Research, the study drew upon data from the UK Clinical Practice Research Datalink, identifying cases of lupus and matching each one by age, gender and practice to four heal...
Source: Arthritis Research UK - May 26, 2016 Category: Rheumatology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Baxter touts data on Theranova Dialyser efficacy, toxin clearance Baxter today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for ...
Source: Mass Device - May 23, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter (NYSE:BAX) today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for treating chronic and acute renal failure. The study data was presented at the European Renal Association and European Dialysis and Transplant Association’s 53rd Congress this week. ”Regardless of where dialysis therapy is performed – in a hospital, in a centre or at home – Baxter is actively researching unique solutions, introducing innovative technologies and elevating scientific exchange to advance renal care. Baxter p...
Source: Mass Device - May 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Dialysis Baxter International Source Type: news

Methadone for fun sake… kidneys are at stake!!! - Chaudhari S, W.hedkar K, Popis-Matejak B, Baumstein D.
Acute renal failure from rhabdomyolysis is a well-established clinical entity; however, rhabdomyolysis exclusively caused by the ingestion of methadone requiring hemodialysis is very uncommon. With a similar mechanism to opiates, methadone can cause rhabdo... (Source: SafetyLit)
Source: SafetyLit - April 13, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Fatal toxic myocarditis induced by paraphenylene diamine: a case report - Jedidi M, Hadj MB, Masmoudi T, Adelkarim SB, Mlayeh S, Dhiab MB, Souguir MK.
Para phenyl diamine (PPD) is an aromatic amine derivative of Aniline that is widely used as a cosmetic product, particularly in hair dye preparations. PPD acute poisoning leads to respiratory distress, rhabdomyolysis, muscle necrosis and renal failure. Car... (Source: SafetyLit)
Source: SafetyLit - April 13, 2016 Category: Global & Universal Tags: Home and Consumer Product Safety Source Type: news

Tourniquets in Field Management of Active Bleeding
This study was groundbreaking. First, it was a prospective study; second, it found a complication rate of 1.7% limited to nerve palsies. These updated findings on complications of the device have helped to allay prior fears of morbidity that deterred tourniquet use. Following suit, the civilian community conducted its own research. Yielding low complication rates and high potential benefits, this research bolstered the recommendation for aggressive early tourniquet use.7 Mirroring the wave of change in military protocols, by 2012 some large metropolitan areas began equipping ambulances with commercial tourniquets and ...
Source: JEMS Patient Care - April 6, 2016 Category: Emergency Medicine Authors: Elisabeth White, MD Tags: Major Incidents Trauma Source Type: news

Could Modern Medicine Be Harming Older Patients?
Medically speaking, if you are above the age of 65, you are considered an "older adult." On conducting rounds on the cardiology unit, I find it rare to see anyone less than 65 years of age. If someone below 50 years old gets admitted, they are almost considered "pediatric" from a cardiovascular perspective. Such observations reflect the realities of modern medicine. Patients are older, more frail, have multiple co-morbidities, and have complex social issues. During the next 25 years, the population age greater than 85 years will be more than double -- from 6.3 million in 2015 to 14.1 million by 2040. Ye...
Source: Healthy Living - The Huffington Post - March 28, 2016 Category: Consumer Health News Source Type: news

Febuxostat for Gout With Renal Failure Appears Feasible (CME/CE)
(MedPage Today) -- Target urate levels reached with no effect on kidney function (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 27, 2016 Category: Geriatrics Source Type: news

Chronic renal failure and an increased risk of osteoporosis
According to researchers in Italy, patients who had chronic renal failure and chronic treatment with anticoagulants or antiepileptic medications were at a higher risk for osteoporosis. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 16, 2016 Category: Endocrinology Source Type: news

Medtronic wins expanded PMA for CoreValve
The FDA cleared expanded indications for Medtronic‘s (NYSE:MDT) CoreValve TAVR devices, now cleared for use in patients with end-stage renal disease and those with low-grade, low-flow aortic stenosis. Medtronic won approval from the FDA to modify the CoreValve’s labeling in November which included both its CoreValve and CoreValve Evolut R systems. The changes to the labeling were approved based on Medtronic’s CoreValve U.S. expanded use study of high and very-high-risk subjects at need for aortic valve replacements, according to an email FierceMedicalDevices received from a Medtronic spokesperson. Da...
Source: Mass Device - February 4, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Replacement Heart Valves Medtronic Source Type: news

MassDevice.com +3 | The top 3 medtech stories for February 1, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Medtronic gets into renal care with Bellco acquisition Medtronic said that it acquired renal care products make Bellco for an indisclosed amount and plans to fold it into a newly created renal care solutions division. Fridley, Minn.-based Medtronic said Mirandola, Italy-based Bellco makes devi...
Source: Mass Device - February 1, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news

Medtronic gets into renal care with Bellco acquisition
Medtronic (NYSE:MDT) said today that it acquired renal care products make Bellco for an undisclosed amount and plans to fold it into a newly created renal care solutions division. Fridley, Minn.-based Medtronic said Mirandola, Italy-based Bellco makes devices designed to treat end-stage renal failure, multiple organ failure and sepsis, including dialyzers and chronic and acute dialysis machines. The products are on the market in more than 50 nations, Medtronic said. “ESRD patients require dialysis for the remainder of their lives, or until a viable kidney transplant becomes available. We believe Medtro...
Source: Mass Device - February 1, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Mergers & Acquisitions Wall Street Beat Bellco Medtronic Renal Source Type: news

Extracorporeal treatment for digoxin toxicity: just say no
3 out of 5 stars Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup. Mowry JB et al. Clin Toxicol 2016 Feb;54:103-14. Abstract “Forced diuresis, and hemodialysis are ineffective in enhancing the elimination of digoxin because of its large volume of distribution (4-10 L/kg), which makes it relatively inaccessible to these techniques.” Goldfrank’s Toxicologic Emergencies (Tenth Edition, 2015) That one sentence from the latest edition of Goldfrank’s tells you all you need to know about the use of extracorporeal treatment (ECTR) &nbs...
Source: The Poison Review - January 28, 2016 Category: Toxicology Authors: Leon Tags: Medical digoxin toxicity extracorporeal treatment extrip Fab fragment hemodialysis hemoperfusion Source Type: news

Review of synthetic cannabinoids out-of-date as soon as it’s published
3 out of 5 stars A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Tait RJ et al. Clin Toxicol 2016 Jan;54:1-13. Abstract This paper review clinical literature related to use of synthetic cannabinoids (SCs) through the end of 2015. Although it seems comprehensive, and cites 108 references, it is of course already at least 18 months out-of-date. The number of cases involving exposure to SC surged during 2015. For example, although the authors of this paper identified 22 deaths associated with SCs, according to CDC data in the first 6 months of...
Source: The Poison Review - January 20, 2016 Category: Toxicology Authors: Leon Tags: Medical K2 spice synthetic cannabinoids systematic review Source Type: news

Teach Providers to Appreciate the Small Parts of the Job
When the public thinks or hears about firefighting, what typically comes to mind are all the big jobs: multi-alarm fires, extrications, hazardous materials mitigations, collapsed structure and confined space rescues—the kinds of calls we worry about but also somewhat ironically look forward to. This all looks a little different on the medical side. Although many of the things we encounter in suppression can certainly be dramatic and critically important, there are many more opportunities to save or change the course of a life on the EMS end of things. That’s not to belittle or to trivialize the importance of fi...
Source: JEMS Administration and Leadership - January 18, 2016 Category: Emergency Medicine Authors: Neal Richmond, MD Tags: Leadership & Professionalism Columns Source Type: news